Immunodiagnostic Systems Holdings plc (“the Company”), a leading producer of diagnostic testing kits, received notification on 19 July 2010 that on that day 1,729,517 ordinary shares of 2p each in the Company (the “Ordinary Shares”), were successfully placed with institutional investors by directors at a price of 725p. The shares were placed in response to […]
Immunodiagnostic Systems Holdings plc (“IDS” or “the Company”), a leading producer of specialist diagnostic testing kits for the clinical and research markets, gives notice of a number of proposed changes at board level which reflect the Board’s desire to ensure a stable plan of succession for the management of the business. On October 1st 2010 […]
Immunodiagnostic Systems Holdings plc (“IDS” or the “Company” or the “Group”), a leading producer of diagnostic testing kits for the clinical and research markets, announces its preliminary results for the year ended 31 March 2010. IDS operates in the in-vitro diagnostics (“IVD”) market. The Company designs, manufactures and sells immunoassay kits which are used to […]
